Streetbeat News

Partnerships

TRNR

Interactive Strength, Inc. d/b/a FORME (NASDAQ:TRNR) has announced a strategic partnership with healthcare payment provider Truemed. The collaboration allows U.S. customers to use funds from their HSA and FSA programs to purchase FORME's personal training and smart home gyms, resulting in average after-tax savings between 30% and 40%. This partnership is expected to enhance FORME's B2C positioning and complement its B2B initiative of acquiring CLMBR.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:34 pm

NVAX

Novavax has announced that it will make its Covid-19 vaccine available through Group Purchasing Organization (GPO) agreements, including Vizient, Inc., Premier, and Healthtrust Purchasing Group.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:30 pm

NVAX

Novavax's Covid-19 vaccine doses are now available at major retail pharmacies across the U.S. The company is also working with additional retailers and expects its network of partners providing its updated Covid-19 vaccine to continue to grow.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:29 pm

LEXX

Lexaria Bioscience Corp. (NASDAQ:LEXX) has granted a new global, exclusive license to use DehydraTECH technology to SulfoSyn Limited. The license is for all non-pharmaceutical uses of sulforaphane world-wide. Lexaria is also being contracted to perform certain DehydraTECH-related manufacturing operations at its US partner facility on behalf of SulfoSyn for an initial term of 2 years.

Portfolio Pulse from Happy Mohamed

October 13, 2023 | 1:07 pm

AEY

ADDvantage Technologies Group, Inc. (NASDAQ:AEY) announced that its subsidiary, Fulton Technologies, has signed multi-year agreements with some of the largest optical communications OEMs in the US. Under these agreements, Fulton's Broadband division is authorized to provide fiber design, engineering, and construction services throughout the US. This comes after the recent expansion of Broadband services by Fulton and is expected to improve legacy deployment methods.

Portfolio Pulse from Happy Mohamed

October 13, 2023 | 1:02 pm

SYRA

Syra Health has formed a strategic partnership with Maricopa County to address healthcare disparities. The partnership aims to improve access to healthcare services for underserved communities in the county.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:01 pm

ERJ

Embraer (NYSE:ERJ) has extended its multi-year contract with Sky High Aviation for the Pool Program. The agreement allows the Dominican Republic-based airline to continue receiving support for repairable components for its E-190 and E-175 aircraft. Embraer has been supporting Sky High Aviation since it became the first E-Jet operator in the Caribbean last year. The Pool Program currently supports over 60 airlines worldwide.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:44 pm

GPAK

Gamer Pakistan Inc. (NASDAQ:GPAK) announced that its subsidiary K2 Gamer has received its first major sponsorship from 313 Mobiles for the Super Mega Pakistan Universities Esports Championship 2023. The championship is expected to attract the best gamers from across the higher education institutions of Pakistan and help to further develop the esports ecosystem and community in the country.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:38 pm

ADN

Advent Technologies Holdings, Inc. (NASDAQ:ADN) participated in the inaugural Clean Transition Dialogue on Hydrogen organized by the European Commission. The event focused on the role of the hydrogen sector in Europe's energy independence. Advent's CEO, Dr. Vasilis Gregoriou, briefed EU President Ursula von der Leyen on the progress of projects endorsed by the EU under the Important Project of Common European Interest (IPCEI) in hydrogen technology. He also discussed the delay in securing funding for Advent's EU-ratified Green HiPo project in Greece, which aims to develop, design, and produce HTPEM fuel cell systems and electrolyser systems.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:37 pm

ANIX

Anixa Biosciences (NASDAQ:ANIX) has completed the treatment of the first patient cohort in its ongoing clinical trial of CAR-T therapy for ovarian cancer, in partnership with Moffitt Cancer Center. The first cohort received the same dose of engineered T-cells, with no dose-limiting toxicities observed. The trial will now begin enrolling patients in the second dose cohort, who will receive three times the cell dose compared to the first cohort. The study aims to evaluate the therapy's safety, determine the maximum tolerated dose of T-cells targeting the follicle stimulating hormone receptor (FSHR), and preliminarily assess clinical activity.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:35 pm